Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
Year: 2011
Type: review
Source: Journal of Clinical Oncology
Authors: Ayalew Tefferi, William Vainchenker
Institutions: Mayo Clinic, Inserm, Institut Gustave Roussy
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, primary myelofibrosis, JAK2 mutation, MPL mutation, risk stratification, treatment options, hydroxyurea, interferon-alpha, JAK inhibitors, pomalidomide, allogeneic stem cell transplantation, TET2 mutation, ASXL1 mutation, EZH2 mutation, IDH mutation, IKZF1 mutation, CBL mutations
Open Access status: closed
OpenAlex ID: W2085325045
